3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
8
Terminated
5
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
38
Myelodysplastic Syndromes
14
Leukemia, Myelomonocytic, Chronic
10
Leukemia
4
Myeloproliferative Disorders
3
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Interventions
Rituximab
21
Cyclophosphamide
21
fludarabine
12
fludarabine phosphate
10
pirtobrutinib
6
obinutuzumab
6
ibrutinib
6
acalabrutinib
6
Tacrolimus
6
Mycophenolic Acid
6
Melphalan
6
Magnetic Resonance Spectroscopy
6
Biopsy
6
venetoclax
5
tocilizumab
5
X-Rays
5
Whole-Body Irradiation
5
Specimen Handling
5
Prednisone
5
Phantoms, Imaging
5
Peripheral Blood Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
Etoposide
5
Doxorubicin
5
Thiotepa
4
Lenalidomide
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Cytarabine
4
Bendamustine Hydrochloride
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Lymphoma, Non-Hodgkin
×
Azacitidine
×
Clear all
NCT01333046
2026-06-03
TACTAL
Baylor College of Medicine
Phase 1
Active not recruiting
36 enrolled